Genitourinary Malignancies Branch (GMB)

The Genitourinary Malignancies Branch (GMB) focuses on investigating the biology of genitourinary cancers, developing new strategies for treating those cancers, and evaluating new therapeutic approaches through science-driven clinical research. These clinical trials investigate novel approaches in immunotherapy, hormonal therapy, chemotherapy combinations, and small-molecule targeted therapy. CMRP support includes recruiting patients, performing initial assessments, and coordinating studies for clinical trials in collaboration with a Principle Investigator and other team members.